Regulating Cathelicidin Expression for Disease Therapy
调节导管素表达以治疗疾病
基本信息
- 批准号:8049149
- 负责人:
- 金额:$ 35.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-04-15 至 2013-03-31
- 项目状态:已结题
- 来源:
- 关键词:AchievementAntibiotic ResistanceAtopic DermatitisAutomobile DrivingBacteriaBindingBiologicalCCAAT-Enhancer-Binding ProteinsCREB1 geneCebidaeCholecalciferolClinicalDefensinsDevelopmentDiseaseEpithelialEpithelial CellsFamilyGene ExpressionGene Expression RegulationGenesGeneticGenetic TranscriptionGoalsHealthHematopoieticHost DefenseHumanImmuneIn VitroInfectionInflammationInvestigationKnowledgeLeadMammalsMediatingMicrobeMolecularMyelogenousMyeloid CellsPharmaceutical PreparationsPrimatesProcessProsimiiRegulationResearchRetinoidsSepsisSignal PathwaySteroidsTestingTherapeuticTherapeutic UsesThyroid Hormone ReceptorTissuesTranscriptional RegulationTransgenic MiceVitamin DVitaminsactivating transcription factorantimicrobialantimicrobial peptideantimicrobial peptide LL-37cathelicidincell typedriving forcehuman diseasein vivoin vivo Modelinsightinterestmicrobialmouse modelneutrophilnovelpathogenpromoterresponsesmall moleculetranscription factor
项目摘要
DESCRIPTION (provided by applicant): Infections by antibiotic resistant bacteria and the potential for sepsis are a major health concern. Antimicrobial peptides (AMPs) like cathelicidins (CAMP) and defensins are generating considerable interest for therapeutic use as potential bactericidals, anti-LPS drugs and modulators of inflammation, and other potential uses. However, the mechanisms governing CAMP expression are largely unknown. The central hypothesis driving the proposed research is that transcription factors (TFs) from the CCAAT/enhancer binding protein (C/EBP), ETS/PU.1, CREB/ATF and the steroid/thyroid hormone receptor families control constitutive and inducible expression of CAMP in hematopoietic and epithelial tissues. We propose an investigation directed towards achieving 3 Specific Aims: [1] Identify the TFs in myeloid and epithelial cells that regulate CAMP gene transcription; [2a] Determine extent of vitamin DS-mediated induction of CAMP in various human cell types and atopic dermatitis; [2b] Identify mechanism of synergistic activation of human CAMP gene expression by retinoids and vitamin D3; [2c] Discover novel small molecules that regulate CAMP gene expression; [3] Elucidate the biological importance and potential therapeutic benefits of vitamin D3 regulation of CAMP gene expression. Specific Aims 1 and 2 will generate a comprehensive assessment of the transcriptional regulation of the CAMP gene in the myeloid and epithelial compartments and identify additional compounds that either alone or in combination with vitamin D3 may prove therapeutically useful. Specific Aim 3 will characterize the evolutionary and biological importance of antimicrobial gene regulation by vitamin D and will use parallel in vitro and in vivo mouse models that exploit a powerful genetic approach to critically examine how vitamin D3 regulates expression of CAMP in response to microbial invasion or challenge with pathogen-derived molecules. Achievement of these specific aims will provide a comprehensive knowledge of the transcriptional regulation of the CAMP gene and demonstrate the biological importance of vitamin D3-mediated regulation of antimicrobial peptides. This knowledge will lead to the development of approaches for extrinsically manipulating endogenous CAMP expression for systemic and localized therapeutic benefit of human diseases.
描述(由申请人提供):抗生素耐药菌感染和败血症的可能性是一个主要的健康问题。抗菌肽(AMP),如凯萨林菌素(CAMP)和防御素,作为潜在的杀菌剂、抗脂多糖药物和炎症调节剂以及其他潜在用途,在治疗用途方面引起了相当大的兴趣。然而,CAMP表达的调控机制在很大程度上是未知的。推动这项拟议研究的中心假设是,来自CCAAT/增强子结合蛋白(C/EBP)、ETS/PU.1、CREB/ATF和类固醇/甲状腺激素受体家族的转录因子(TF)控制CAMP在造血和上皮组织中的组成型和诱导型表达。我们提出了一项旨在实现3个特定目的的研究:[1]鉴定髓样和上皮细胞中调节CAMP基因转录的TF; [2a]确定维生素DS介导的CAMP诱导在各种人类细胞类型和特应性皮炎中的程度; [2b]鉴定类维生素A和维生素D3协同激活人类CAMP基因表达的机制; [2c]确定维生素D3对人类CAMP基因表达的影响。[2c]发现调节CAMP基因表达的新型小分子; [3]阐明维生素D3调节CAMP基因表达的生物学重要性和潜在治疗益处。具体目标1和2将产生对骨髓和上皮隔室中CAMP基因的转录调控的全面评估,并鉴定单独或与维生素D3组合可能证明治疗有用的其他化合物。具体目标3将表征维生素D对抗菌基因调控的进化和生物学重要性,并将使用平行的体外和体内小鼠模型,这些模型利用强大的遗传方法来严格检查维生素D3如何调节CAMP的表达,以应对微生物入侵或病原体衍生分子的挑战。这些具体目标的实现将提供一个全面的知识的CAMP基因的转录调控,并证明维生素D3介导的抗菌肽的调节的生物学重要性。这些知识将导致开发外部操纵内源性CAMP表达的方法,以获得人类疾病的系统性和局部治疗益处。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The vitamin D-antimicrobial peptide pathway and its role in protection against infection.
- DOI:10.2217/fmb.09.87
- 发表时间:2009-11
- 期刊:
- 影响因子:3.1
- 作者:Gombart AF
- 通讯作者:Gombart AF
Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis.
- DOI:10.1086/596314
- 发表时间:2009-02-15
- 期刊:
- 影响因子:0
- 作者:Gombart AF;Bhan I;Borregaard N;Tamez H;Camargo CA Jr;Koeffler HP;Thadhani R
- 通讯作者:Thadhani R
Regulation of antimicrobial peptide gene expression by nutrients and by-products of microbial metabolism.
- DOI:10.1007/s00394-012-0415-4
- 发表时间:2012-12
- 期刊:
- 影响因子:5
- 作者:Campbell Y;Fantacone ML;Gombart AF
- 通讯作者:Gombart AF
Regulation of the human cathelicidin antimicrobial peptide gene by 1α,25-dihydroxyvitamin D3 in primary immune cells.
- DOI:10.1016/j.jsbmb.2014.02.004
- 发表时间:2014-09
- 期刊:
- 影响因子:4.1
- 作者:Lowry, Malcolm B.;Guo, Chunxiao;Borregaard, Niels;Gombart, Adrian F.
- 通讯作者:Gombart, Adrian F.
Exaptation of an ancient Alu short interspersed element provides a highly conserved vitamin D-mediated innate immune response in humans and primates.
- DOI:10.1186/1471-2164-10-321
- 发表时间:2009-07-16
- 期刊:
- 影响因子:4.4
- 作者:Gombart AF;Saito T;Koeffler HP
- 通讯作者:Koeffler HP
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Adrian Friedrich Gombart其他文献
Adrian Friedrich Gombart的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Adrian Friedrich Gombart', 18)}}的其他基金
Vitamin D, Xanthohumol and Nuclear Receptors: Targeting Immunity, Microbiota and
维生素 D、黄腐酚和核受体:针对免疫、微生物群和
- 批准号:
9150689 - 财政年份:2015
- 资助金额:
$ 35.14万 - 项目类别:
Vitamin D, Xanthohumol and Nuclear Receptors: Targeting Immunity, Microbiota and
维生素 D、黄腐酚和核受体:针对免疫、微生物群和
- 批准号:
9332325 - 财政年份:2015
- 资助金额:
$ 35.14万 - 项目类别:
Vitamin D, Xanthohumol and Nuclear Receptors: Targeting Immunity, Microbiota and
维生素 D、黄腐酚和核受体:针对免疫、微生物群和
- 批准号:
9759772 - 财政年份:2015
- 资助金额:
$ 35.14万 - 项目类别:
Regulating Cathelicidin Expression for Disease Therapy
调节导管素表达以治疗疾病
- 批准号:
8093622 - 财政年份:2010
- 资助金额:
$ 35.14万 - 项目类别:
Regulating Cathelicidin Expression for Disease Therapy
调节导管素表达以治疗疾病
- 批准号:
8072929 - 财政年份:2010
- 资助金额:
$ 35.14万 - 项目类别:
Regulating Cathelicidin Expression for Disease Therapy
调节导管素表达以治疗疾病
- 批准号:
7700943 - 财政年份:2007
- 资助金额:
$ 35.14万 - 项目类别:
Regulating Cathelicidin Expression for Disease Therapy
调节导管素表达以治疗疾病
- 批准号:
7587978 - 财政年份:2007
- 资助金额:
$ 35.14万 - 项目类别:
Regulating Cathelicidin Expression for Disease Therapy
调节导管素表达以治疗疾病
- 批准号:
7394988 - 财政年份:2007
- 资助金额:
$ 35.14万 - 项目类别:
Regulating Cathelicidin Expression for Disease Therapy
调节导管素表达以治疗疾病
- 批准号:
7259581 - 财政年份:2007
- 资助金额:
$ 35.14万 - 项目类别:
Regulating Cathelicidin Expression for Disease Therapy
调节导管素表达以治疗疾病
- 批准号:
7786268 - 财政年份:2007
- 资助金额:
$ 35.14万 - 项目类别:
相似海外基金
Ecological and Evolutionary Drivers of Antibiotic Resistance in Patients
患者抗生素耐药性的生态和进化驱动因素
- 批准号:
EP/Y031067/1 - 财政年份:2024
- 资助金额:
$ 35.14万 - 项目类别:
Research Grant
Collaborative Research: Leveraging the interactions between carbon nanomaterials and DNA molecules for mitigating antibiotic resistance
合作研究:利用碳纳米材料和 DNA 分子之间的相互作用来减轻抗生素耐药性
- 批准号:
2307222 - 财政年份:2024
- 资助金额:
$ 35.14万 - 项目类别:
Standard Grant
Molecular Epidemiology of Antibiotic Resistance in Clostridioides difficile
艰难梭菌抗生素耐药性的分子流行病学
- 批准号:
502587 - 财政年份:2024
- 资助金额:
$ 35.14万 - 项目类别:
Collaborative Research: Leveraging the interactions between carbon nanomaterials and DNA molecules for mitigating antibiotic resistance
合作研究:利用碳纳米材料和 DNA 分子之间的相互作用来减轻抗生素耐药性
- 批准号:
2307223 - 财政年份:2024
- 资助金额:
$ 35.14万 - 项目类别:
Standard Grant
The roles of a universally conserved DNA-and RNA-binding domain in controlling MRSA virulence and antibiotic resistance
普遍保守的 DNA 和 RNA 结合域在控制 MRSA 毒力和抗生素耐药性中的作用
- 批准号:
MR/Y013131/1 - 财政年份:2024
- 资助金额:
$ 35.14万 - 项目类别:
Research Grant
Determining structural dynamics of membrane proteins in their native environment: focus on bacterial antibiotic resistance
确定膜蛋白在其天然环境中的结构动力学:关注细菌抗生素耐药性
- 批准号:
MR/X009580/1 - 财政年份:2024
- 资助金额:
$ 35.14万 - 项目类别:
Fellowship
CAREER: Systems Microbiology and InterdiscipLinary Education for Halting Environmental Antibiotic Resistance Transmission (SMILE HEART)
职业:阻止环境抗生素耐药性传播的系统微生物学和跨学科教育(SMILE HEART)
- 批准号:
2340818 - 财政年份:2024
- 资助金额:
$ 35.14万 - 项目类别:
Continuing Grant
Reinforcing the battle at the bacterial cell wall: Structure-guided characterization and inhibition of beta-lactam antibiotic resistance signalling mechanisms
加强细菌细胞壁的战斗:β-内酰胺抗生素耐药信号机制的结构引导表征和抑制
- 批准号:
480022 - 财政年份:2023
- 资助金额:
$ 35.14万 - 项目类别:
Operating Grants
The spread of antibiotic resistance in bacteria-plasmid networks
抗生素耐药性在细菌-质粒网络中的传播
- 批准号:
BB/X010473/1 - 财政年份:2023
- 资助金额:
$ 35.14万 - 项目类别:
Fellowship
An RNA Nanosensor for the Diagnosis of Antibiotic Resistance in M. Tuberculosis
用于诊断结核分枝杆菌抗生素耐药性的 RNA 纳米传感器
- 批准号:
10670613 - 财政年份:2023
- 资助金额:
$ 35.14万 - 项目类别:














{{item.name}}会员




